|
| Home - Natriumpentosanpolysulfat (B01AX05) |
| |
| B01AX05 - Fondaparinux | ATC-DDD Version 2016. Source: WHO | | B - Blood and Blood Forming Organs | | |
| | B01 - Antithrombotic Agents | | |
| | B01A - Antithrombotic Agents | | |
| | B01AX - Other Antithrombotic Agents | | | The DDD for caplacizumab is 10 mg (P) based on the European labelling and equivalent to 11 mg in the USA labelling.
|
| |
|
|
|
